Poging GOUD - Vrij
Does India's Fiscal Profile Need a Facelift?
Mint Chennai
|January 21, 2025
The role of fiscal policy becomes more crucial in the current cyclical slowdown
Policymaking is all about trade-offs. The upcoming budget faces an acute policy trade-off between nurturing the fading growth and diminishing fiscal space with challenging debt dynamics. At the same time, renewed uncertainties around global markets and ensuing tighter financial conditions would also weigh on the fiscal reaction function. The role of fiscal policy becomes more crucial in the current cyclical slowdown, as part of the growth hit has been attributed to tighter fiscal and monetary stance in general, while private economic agents (consumption and investment) have also stayed less robust or missing.
The policy aim thus is to ensure keeping the overall expenditure-to-GDP ratio healthy, with high revenue expenditure (revex) and healthy capital expenditure (capex) spending. Even as additional support to some segments of the economy is warranted, a delicate balance needs to be maintained, ensuring the fiscal impulse is maximized to boost potential growth. However, all of this would still have to be achieved while adhering to the medium-term fiscal sustainability.
Dit verhaal komt uit de January 21, 2025-editie van Mint Chennai.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
